LA Jolla Pharma (LJPC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 12-2015 | 12-2014 | 12-2013 | 12-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 65,926 | 126,704 | 48,592 | 8,666 | 3,405 |
| TOTAL | $67,431 | $127,545 | $50,257 | $8,709 | $3,430 |
| Non-Current Assets | |||||
| PPE Net | 3,145 | 1,732 | 279 | 38 | 0 |
| Other Non-Current Assets | 219 | 70 | 0 | 0 | 0 |
| TOTAL | $3,364 | $1,802 | $279 | $38 | $N/A |
| Total Assets | $70,795 | $129,347 | $50,536 | $8,747 | $3,430 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 6,652 | 3,052 | 730 | 834 | 92 |
| Accrued Expenses | 2,982 | 1,768 | 1,350 | 260 | 124 |
| TOTAL | $9,758 | $4,820 | $2,080 | $1,094 | $216 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 124 | N/A | N/A | N/A | N/A |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $9,758 | $4,820 | $2,080 | $1,094 | $216 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 18,262 | N/A | 15,243 | 7,257 | 378 |
| Common Shares | 2 | 2 | 2 | 4 | 1 |
| Retained earnings | -606,711 | -528,526 | -486,614 | -465,301 | -447,366 |
| Other shareholders' equity | 6,643 | 6,643 | 6,715 | 10,266 | 10,907 |
| TOTAL | $61,037 | $124,527 | $48,456 | $7,653 | $3,214 |
| Total Liabilities And Equity | $70,795 | $129,347 | $50,536 | $8,747 | $3,430 |